![]() Pfizer vaccine: Pfizer enrolled 4,500 children in its clinical trials. Here are some more details about the safety profiles for each one: And children get smaller doses than adults do, yet they mount robust antibody responses with no safety concerns.” “We are fortunate to live in a country that has these oversights in place. “There are many processes in place to ensure safety, including oversight from vaccine advisory groups, the FDA, and the vaccine manufacturers,” Dr. ![]() ( Click here for an FDA analysis of Pfizer’s data analysis or here for an FDA analysis of Moderna's data.) The FDA released its own analysis of the vaccines, saying they did not raise safety concerns and were effective. ![]() ![]() To receive an EUA, Pfizer and Moderna separately had to present the results of clinical trials that showed their vaccines to be both safe and effective in the target age groups.Īlthough the results are preliminary and have not yet been peer-reviewed or published in academic journals, the data was reviewed by the FDA and a committee of independent vaccine experts. Are the COVID vaccines safe for young children? Similarly, a single dose of Moderna’s bivalent booster is available to children 6 years and older at least two months after they complete either primary vaccination or receive a booster dose with any authorized or approved COVID-19 vaccine. In addition, a single dose of Pfizer’s bivalent booster is available to children 5 years and older at least two months after they complete either primary vaccination or receive a booster dose with any authorized or approved COVID-19 vaccine. Children ages 6 months through 4 years who have already completed their three-dose primary series with the original Pfizer vaccine are not eligible for a booster dose of the bivalent vaccine at this time.įor Moderna, children ages 6 months through 5 years who received the original, monovalent Moderna vaccine as their primary series can receive a single booster of the Moderna bivalent vaccine. Shortly after, the CDC signed off on the decision.įor Pfizer, children ages 6 months through 4 years who have not started their three-dose primary series of the original, monovalent vaccine (or have not yet had the third dose) will receive the Pfizer bivalent vaccine as their third dose after completing two doses of the original vaccine. In December, the FDA granted an EUA to Pfizer and Moderna for their bivalent booster for younger children. (Pfizer vaccines for ages 5 and up are already available.) The Moderna vaccine is authorized for ages 6 months to 6 years. The Pfizer vaccine is authorized and approved for children ages 6 months to 5 years. Which COVID vaccines are now authorized for young children? Sude and Thomas Murray, MD, PhD, a pediatric infectious diseases specialist. To answer parents’ questions about vaccinating young children, we talked with Dr. “And as long as the virus spreads from person to person, the virus can keep changing and evolving into new variants.” “While a significant proportion of the population was not eligible for vaccination, there was still the opportunity for widespread circulation of COVID among children, who could then keep transmitting it to older people,” she says. Leslie Sude, MD, a Yale Medicine pediatrician, says opening vaccination to this younger group is yet another way to manage the pandemic to make everyone safer. There are roughly 18 million children under the age of 5 in the United States. This compares to a vaccination rate of 60% among kids ages 12 to 17. For ages 2 to 4, it falls to about 3% and to less than 2% for children under age 2. Nationally only about 32% of children ages 5 to 11 are fully vaccinated, according to the CDC as of Oct. Vaccination uptake in young children has not been high to date. While some parents have been counting down the days and are eager to vaccinate their kids, others are hesitant and have lingering questions: Are the vaccines safe? How effective are they, especially against Omicron? Should a child who recently had COVID-19 get vaccinated? In mid-June, the Food and Drug Administration (FDA) granted emergency use authorization (EUA) to Pfizer’s COVID-19 vaccine for children ages 6 months to 5 years, as well as to Moderna's vaccine for kids ages 6 months to 6 years. The Centers for Disease Control and Prevention (CDC) soon after recommended the vaccines, which should become available early next week. ![]() After multiple delays, very young children are finally eligible for COVID-19 vaccination. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |